Neumora Therapeutics Inc. (NASDAQ: NMRA) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Neumora Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $13.77 and fluctuated between $14.03 as its day high and $13.17 as its day low. The current market capitalization of Neumora Therapeutics Inc. is $2.19B. A total of 0.66 million shares were traded on the day, compared to an average of 433.21K shares.

In the most recent transaction, Burow Kristina bought 3,357 shares of NMRA for 11.98 per share on Nov 14 ’23. After the transaction, the Director now owns 4,131,207 company shares. In a previous transaction on Nov 14 ’23, ARCH Venture Partners XII, LLC bought 3,357 shares at 11.98 per share. NMRA shares that 10% Owner owns now total 4,131,207.

Among the insiders who bought shares, ARCH Venture Partners XII, LLC acquired of 31,653 shares on Nov 13 ’23 at a per-share price of $11.75. This resulted in the 10% Owner holding 4,127,850 shares of NMRA after the transaction. In another insider transaction, Burow Kristina bought 31,653 shares at $11.75 per share on Nov 13 ’23. Company shares held by the Director now total 4,127,850.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NMRA has a high of $21.00 and a low of $9.35.

As of this writing, NMRA has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.4. The company reported an EPS of -$1.14 in the last quarter, which was -216.70% lower than expectations of -$0.36.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NMRA’s latest balance sheet shows that the firm has $409.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.05M in debt and $23.28M in liabilities at the time. Its Book Value Per Share was $2.95, while its Total Shareholder’s Equity was -$325.22M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NMRA is Buy with a score of 4.57.

Most Popular

Related Posts